{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-069026","form_type":"8-K","ticker":"BDTX","cik":"0001701541","company_name":"Black Diamond Therapeutics, Inc.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.895217+00:00","generated_at":"2026-06-25T03:59:31.281286+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Black Diamond Therapeutics announces 2022 annual meeting voting results","bullets":["Three Class II directors elected: Ali Behbahani (18.2M for), Garry Menzel (18.6M for), Samarth Kulkarni (21.8M for).","PricewaterhouseCoopers LLP ratified as auditor for FY2022 with 30.1M for, 14k against, 55k abstain.","Quorum of 30.2M shares out of 36.3M outstanding was present at the June 7, 2022 virtual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-069026","json":"https://secwatch.observer/filing/0001104659-22-069026.json","markdown":"https://secwatch.observer/filing/0001104659-22-069026.md","text":"https://secwatch.observer/filing/0001104659-22-069026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701541/000110465922069026/0001104659-22-069026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701541/000110465922069026/tm2217931d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:59:31.281286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}